Abstract. Esterification of acetate with generic pharmaceutical compound has been commonly employed to produce ester prodrug for improving its potency when compared with the mother compound. Acetate, on the other hand, has been recognized to have inhibitory effect on the respiratory biochemistry. Here we demonstrate that acetate at a concentration of 400 μM exhibited significant growth inhibitory activity on two human cancer cell lines, the MDAMB-231 breast cancer and the SKHep-1 hepatoma cell lines. To establish the ester prodrug with multi-acetate ester conjugates as our experimental model, one molecule of (-)-epigallocatechin gallate was required to conjugate with eight molecules of acetate forming the corresponding (-)-epigallocatechin gallate octaacetate prodrug. Chemical structure of this epigallocatechin gallate octaacetate ester prodrug was confirmed by both 13 C and 1 H nuclear magnetic resonance spectra and mass spectrometry. Further cytotoxic assay using both MDAMB-231 and SKHep-1 human carcinoma cell lines showed that acetate at a concentration of 400 μM exhibits an additional cytotoxic effect with (-)-epigallocatechin gallate at a concentration of 50 μM, although the additional effect was not as high as (-)-epigallocatechin gallate octaacetate ester prodrug alone at a concentration of 50 μM. Our results thus raise a pharmacological consideration of using multi-acetate conjugate as the ester prodrug where the release of free acetate by esterase could be part of the explanation for the improved in vitro cytotoxicity.
Introduction
The conjugation of acetate to generic drug is one of the common methods to prepare the corresponding prodrug. The presence of esterase could hydrolyse the ester bond and this could result in releasing the active form of the drug, able to exert its pharmaceutical action. Such ester based prodrugs were shown to have improved permeability to cells (1, 2) .
On the other hand, acetate has been shown to have effects on intermediary metabolism in heart, accordingly to evidence demonstrating that exposure of cardiac tissue to acetate interrupts glycolysis (3) . The underlying mechanistic action might involve the feedback inhibitory effect of phosphofructokinase by the condensation product of acetyl Coenzyme A in the citric acid cycle, the citrate (4).
We were interested to verify whether the by-product of acetate linked prodrug, the acetate, would also have profound biological effects on cancer cells in vitro. To address this issue, we investigated the possible concentration of acetate ions that would possess significant growth inhibitory potential on two human cancer cell lines, including the MDAMB-231 breast cancer cells and SKHep-2 hepatoma cells. Then (-)-epigallocatechin gallate (EGCG) was used as a simulatory model to synthesize its octaacetate ester 'prodrug' and the chemical structure of the resulting synthetic product was confirmed by 1 H, 13 C nuclear magnetic resonance (NMR) spectra and mass spectrometry (MS). We compared the growth inhibitory activity of acetate ion, (-)-EGCG and (-)-EGCG octaacetate ester prodrug on the proliferation of these two human carcinoma cell lines. Our results showed that acetate has additional inhibitory action on these two cancer cell lines when administered together with (-)-EGCG. We suggest that a pharmacological consideration on prodrug design should be considered if multiple acetates are used to produce the corresponding ester prodrug. (-)-EGCG was purchased from Sigma-Aldrich. All other chemicals were purchased from commercial suppliers and used without further purification. Pyridine was freshly distilled from sodium under nitrogen. Acetic anhydride was freshly distilled prior to use. All reactions were monitored by analytical thin-layer chromatography (TLC) on Merck aluminum-precoated plates of silica gel 60F 254 with detection by spraying with 5% (w/v) dodecamolybdophosphoric acid in ethanol and subsequent heating. E. Merck silica gel 60 (230-400 mesh) was used for flash chromatography. Chemical structure was confirmed by NMR including 1 H and 13 C spectra and MS, respectively (5, 6) .
Materials and methods

Synthesis of (-)
To a solution of the (-)-EGCG (10 mg, 0.02 mmol) in pyridine (2 ml) was added acetic anhydride (0.5 ml) at room temperature, and the resulting mixture was stirred overnight at room temperature. The reaction mixture was dried under vacuum. The resulting crude solid was dissolved in dichloromethane followed by flash chromatography (hexane-ethyl acetate, 4:1). Fig. 1 shows the reaction scheme.
Cell lines and cell culture. Two human carcinoma cell lines, the MDAMB-231 breast cancer and SKHep-1 hepatoma cell lines, were kindly provided by Professor Gregory Yin Ming Cheng, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong. Both carcinoma cell lines were maintained in RPMI-1640 medium (Sigma Chemical) supplemented with 5% of heat inactivated fetal bovine serum (Hyclone) together with antibiotics involving penicillin and streptomycin. Cells were allowed to grow in a humidified cell culture incubator keeping at 5% carbon dioxide (Nuaire).
Preparation of compounds for cancer cell culture study. Sodium acetate was purchased from Sigma Chemical and dissolved in sterile distilled water to a final stock concentration of 400 mM. Both of the (-)-EGCG and synthetic (-)-EGCG octaacetate ester prodrug were dissolved in dimethylsulfoxide (DMSO) to a final stock concentration of 50 mM. All of them were kept at -20˚C in aliquots until further use.
Antiproliferative and cytotoxic tests. The employed cells were seeded in a 96-well microtitre plate on the first day. On the second day, growth medium was changed and the different tested compounds were added. The maximum concentration of DMSO used never exceeded 0.01% by volume. After 48 h, the intracellular ATP level was measured by using the ATPlite-1step kit (Perkin-Elmer, Life Sciences) for antiproliferative and cytotoxic activity test. The resulting luminescence was recorded according to the instruction manual provided (7). Statistical analysis. Student's t-test was used in data analysis where results were considered as statistically significant when p-value was <0.05 when compared with untreated control.
Morphological monitoring of sodium acetate-treated MDAMB-231 and
Results and Discussion
Synthesis of (-)-EGCG octaacetate ester. We have successfully synthesized the (-)-EGCG octaacetate ester as chemical structure was confirmed by 1 H (Fig. 2 ) and 13 C (Fig. 3 (Fig. 4) .
Antiproliferative and cytotoxic effects of 400 μM acetate. To evaluate the antiproliferative and cyctoxic effects of sodium acetate on both MDAMB-231 and SKHep-1 carcinoma cell lines in vitro, serial concentrations of sodium acetate, ranging from 50 to 400 μM, were tested. We observed that significant inhibitory effect on both cancer cell lines at 400 μM sodium acetate (Fig. 5A) . Morphological investigations suggest that SKHep-1 hepatoma cells are more susceptible to sodium acetate induced apoptosis, since apoptotic features, including round cells, bubbling of cell membrane and cell shrinkage (compare panels E to D in Fig. 5 ) were more obvious than in MDAMB-231 breast cancer cells (compare panels C to B in Fig. 5 ). inhibitory concentration of sodium acetate on MDAMB-231 and SKHep-1 carcinoma cells, we synthesized the octaacetate, in order to compare its activity with its mother compound and sodium acetate. Since esterase hydrolysis of each octaacetate molecular gives out eight equivalent of acetate, it requires 50 μM of (-) ECGC for direct comparison while using 400 μM of octaacetate as our control. Owing to the lack of spectroscopic information of the octaacetate from existing literature, we performed NMR, MS and 2D COSY experiments to further confirm its structure. Once we confirmed the successful synthesis of the octaacetate, we performed experiments aimed to investigate whether the presence of acetate at 400 μM would have any profound effects together with (-)-EGCG at 50 μM when compared with (-)-EGCG octaacetate. As shown in Fig. 6 , even though the sum of decrease in terms of intracellular ATP content was not as low as using (-)-EGCG octaacetate ester alone at 50 μM, the presence of acetate at 400 μM leads to a further additional growth inhibitory effect when co-incubated with (-)-EGCG at 50 μM. These effects were reproducibly observed from both the human cancer cell lines tested.
Growth inhibitory effects of (-)-EGCG, (-)-EGCG
Entry of protonated acetate would cause acidification and activation of Na + /H + exchange. Once inside mitochondria, acetate could exhibit their feedback inhibition on citric acid cycle affecting ATP synthesis. This effect is dominant when the loading concentration of acetate is greater than 400 μM. The (-)-EGCG octaacetate ester has a higher cellular permeability when compared with (-)-EGCG. Intracellular esterase can rapidly hydrolyse the (-)-EGCG octaacetate in order to release (-)-EGCG. Therefore, more (-)-EGCG is available with the cell level to exert its biological action even when both (-)-EGCG and (-)-EGCG octaacetate are loaded at the same concentration of 50 μM. The situation is far more significant and clear as the plasma clearance of (-)-ECGC is very short indeed. This may partly explain why the summated inhibitory effect of acetate at 400 μM together with (-)-EGCG at 50 μM was lower than that of (-)-EGCG octaacetate ester at 50 μM. Nevertheless, the release of acetate and/or protonated acetate by intracellular esterase could be part of the explanation to elucidate the improved in vitro cytotoxicity of the (-)-EGCG octaacetate ester on MDAMB-231 and SKHep-1 carcinoma cells.
Recently, we have demonstrated the paradoxical proliferative effect of iron (II) sulphate on human carcinoma cells when documented by the [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS) assay colourimetric assay (9) . Our results here raise another consideration on novel drug synthesis when using multi-acetates as conjugates to produce ester prodrug because of the inhibitory activity of acetate. We believe that the cytotoxicity of acetate as a side product should be taken into account when designing ester conjugated prodrug and the degree of acetate cytotoxicity would vary with different in vitro conditions. Collectively, it seems that basic fundamental biochemistry and chemistry knowledge is an essential and necessary criterion for those who are working in field of medicinal chemistry.
